Efavirenz
- Product NDC
- 0378-2233
- 11-digit product format
- 003782233
- Labeler code
- 0378
- Product ID
- 0378-2233_4de5ffbd-5845-4cbc-8c08-0ba69d97b9bc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- efavirenz
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA091471
- Marketing category
- ANDA
- Marketing start
- 2018-01-30
- Marketing end
- 2023-01-31
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-2233-93 | 00378223393 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2233-93) | 2018-01-30 | 2023-01-31 | No | No | Current |